Skip to main content
Equibles

Carolyn R. Bertozzi

Board Member

Alnylam Pharmaceuticals, Inc. (ALNY)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Carolyn R. Bertozzi

Carolyn R. Bertozzi is recorded as Board Member at Alnylam Pharmaceuticals, Inc. (ALNY). Alnylam Pharmaceuticals, Inc. reported in an 8-K filed December 3, 2025 that Carolyn R. Bertozzi resigned as director of the Board of Directors, effective December 2, 2025. Alnylam Pharmaceuticals, Inc. reported in an 8-K filed January 6, 2023 that Carolyn R. Bertozzi was appointed Class III director, effective January 5, 2023.

“On December 2, 2025, Michael W. Bonney and Carolyn Bertozzi, Ph.D. provided notice of each of their resignations from the Board of Directors (the “Board”) of Alnylam Pharmaceuticals, Inc. (the “Company”), effective on the same date.”
Alnylam Pharmaceuticals, Inc. Form 8-K, filed December 3, 2025 · Read the filing
“Effective as of January 5, 2023, the Board of Directors (the "Board") of Alnylam Pharmaceuticals, Inc. (the "Company"), following the recommendation of its Nominating and Corporate Governance Committee, expanded the size of the Company's Board from eleven to twelve and elected Dr. Carolyn R. Bertozzi to fill the newly created vacancy.”
Alnylam Pharmaceuticals, Inc. Form 8-K, filed January 6, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Alnylam Pharmaceuticals, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.